Product Licences Sample Clauses

Product Licences. 3.1 As soon as possible after the Execution Date, the LICENSOR shall, at its own cost provide LICENSEE with:
AutoNDA by SimpleDocs
Product Licences. 39 SCHEDULE 9................................................................ 42
Product Licences. 19.1 Full and accurate details of all Product Licences, Third Party Product Licences and Product Licence Dossiers which are required for or relate to the operation of the business of the Company as currently conducted are set out in schedule 8.
Product Licences. 5 5. Warranties........................................................5 6. Payments..........................................................6 7.
Product Licences. 4.1 Novartis will ensure the maintenance as far as possible of the existing registrations of the Product Licences provided, however, that Novartis shall have the right to amend the same in the normal course of business after consultation with Cephalon.
Product Licences. Alpharma shall use its best endeavours at all times to file and prosecute to grant applications for Product Licences in accordance with the Registration Programme, which applications and resulting Product Licences shall be in the name of Alpharma. The Licensor shall, at Alpharma's reasonable request and at Alpharma's expense, co-operate with Alpharma in the submission and prosecution of applications for Product Licences. If any Regulatory Authority other than the FDA requires Alpharma to perform clinical or similar trials (including confirmatory field trials) or present material data or information not generally required by the FDA and the cost to Alpharma of complying with such requirement when compared with the anticipated market for Licensed Products in that country would, in Alpharma's reasonable opinion, be uneconomic, Alpharma shall notify the Licensor and may, with the consent of the Licensor (such consent not to be unreasonably withheld or delayed) abandon that Product Licence application. At the end of each calendar quarter during the Licence Period, Alpharma shall provide the Licensor with a detailed report of its progress with respect to obtaining Product Licences on a country by country basis, and its compliance with the Registration Programme, together with any other information relevant to the Licensed Products. In each January and June of the Licence Period, the Licensor and Alpharma shall discuss the progress of the existing Product Licence applications and the submission of forthcoming Product Licence applications. If there is any delay in obtaining any Product Licence resulting from Alpharma's failure to take (and to continue to take) all such steps with respect to the filing and prosecution process for the Product Licence in question as could reasonably be expected to be taken by a prominent animal health company of international reputation, the Licensor shall have the right, upon written request, to attend meetings between Alpharma and the relevant Regulatory Authority, provided however that the Licensor will use best endeavours at any such meetings not to interfere in the relationship between Alpharma and the relevant Regulatory Authority. Without prejudice to the provisions of Clause 8.1 and 17.6, and subject always to Clause 16, Alpharma shall, in the event that any Product Licence application has not been filed within nine months of the applicable Target Submission Date, pay by way of liquidated damages to the Licensor in respect of...
Product Licences. 5.1 On Completion, the Sellers will deliver to the Purchaser signed copies of such documents, if any, as are required by the applicable Governmental Authorities from the Sellers, as holders of the Product Licences, to enable the Purchaser (or any of its Affiliates nominated by the Purchaser) to make application to the such Governmental Authorities for the grant to the Purchaser (or such Affiliate) of new product licences in the UK and/or Ireland, as applicable, effectively equivalent to the Product Licences (“New Product Licences”) and for the cancellation of the Product Licences at the same time. The Purchaser will submit any such applications duly completed to the relevant Governmental Authority as soon as reasonably practicable after Completion and provide the Sellers with evidence that it has done so.
AutoNDA by SimpleDocs
Product Licences 

Related to Product Licences

  • SOFTWARE PRODUCT LICENSE The SOFTWARE PRODUCT is protected by copyright laws and international copyright treaties, as well as other intellectual property laws and treaties. The SOFTWARE PRODUCT is licensed, not sold.

  • Patent License For patent claims including, without limitation, method, process, and apparatus claims which You or Your Affiliates own, control or have the right to grant, now or in the future, You grant to Us a perpetual, worldwide, non-exclusive, transferable, royalty-free, irrevocable patent license, with the right to sublicense these rights to multiple tiers of sublicensees, to make, have made, use, sell, offer for sale, import and otherwise transfer the Contribution and the Contribution in combination with the Material (and portions of such combination). This license is granted only to the extent that the exercise of the licensed rights infringes such patent claims; and provided that this license is conditioned upon compliance with Section 2.3.

  • Trademark Licenses The parties hereby grant to each other non-exclusive, fully-paid, royalty-free licenses to utilize the other party’s trademarks, as follows:

  • Trademark License System Agency grants to Grantee/Contractor, for the term of the Grant Agreement/Contract, a limited non-exclusive, royalty-free, non-assignable, non-transferable license to reproduce System Agency’s trademarks on published materials in the United States related to the performance of the Grant Agreement/Contract, provided that such license is expressly conditional upon, and subject to, the following:

  • Third Party Licenses If (a) in the opinion of outside patent counsel to Licensee, Licensee, or any of its Affiliates or Sublicensees, cannot Exploit a Licensed Product in a country in the Territory without infringing one or more Patents that have issued to a Third Party in such country, or (b) as a result of any claim made against a Party, or any of its Affiliates or Sublicensees, alleging that the Exploitation of a Licensed Product infringes or misappropriates any Patent or any other intellectual property right of a Third Party in a country in the Territory, a judgment is entered by a court of competent jurisdiction from which no appeal is taken within the time permitted for appeal, such that Licensee cannot Exploit such Licensed Product in such country without infringing the Patent or other proprietary rights of such Third Party, then, in either case, Licensee shall have the first right, but not the obligation to negotiate and to obtain a license from such Third Party as necessary for the Exploitation of any Licensed Product hereunder in such country; provided, however, that NovaDel shall have the sole right to seek any such license with respect to the Licensed Process and shall use commercially reasonable efforts to obtain such a license in its own name from such Third Party in such country, under which NovaDel shall, to the extent permissible under such license, grant a sublicense to Licensee as necessary for Licensee, and any of its Affiliates and Sublicensees, to Exploit the Licensed Product as provided hereunder in such country. Licensee shall be solely responsible for one hundred percent (100%) of all royalty and other obligations with respect to the Exploitation of the Licensed Product; provided, however, that Licensee shall have the right to credit fifty percent (50%) any royalties paid by Licensee, its Affiliates or Sublicensees under such license with respect to such country against the royalty payments to be paid by Licensee to NovaDel with respect to the sale of the Licensed Product(s) under Section 4.1; provided, however, that no royalty payment when due, regardless of the amount or number of credits available to Licensee in accordance with this Agreement, shall be reduced by more than fifty percent (50%) of the amounts otherwise owed pursuant to Section 4.1 in any calendar quarter. Credits not exhausted in any calendar quarter may be carried into future calendar quarters.

  • Sub-Licenses Provider shall be entitled to grant non-perpetual, non-exclusive and non-transferable sub-licenses to Customer for the applicable Order Form Term, limited to providing Customer Users Screen Access to the Software (the “Sub-Licenses”).

  • Licences 11.1 The Service Provider shall ensure that all the necessary licences, all other authorisations, permissions, consents, approvals and dispensations which it may require from time to time for the provision of the Services are in place for the Term.

  • Import Licensing 1. Each Party shall ensure that all automatic and non- automatic import licensing measures are implemented in a transparent and predictable manner, and applied in accordance with the Agreement on Import Licensing Procedures in Annex 1A to the WTO Agreement.

  • Intellectual Property Licenses Notwithstanding anything to the contrary contained in the TSA, and except as otherwise provided in Section 5.13 of the SPA, it shall be the responsibility of the Receiving Party (at the Receiving Party’s sole cost and expense) to obtain all licenses associated with the use of third party intellectual property, including but not limited to copyrights (e.g., software), trademarks and patents (and/or consents and extensions relating to such licenses), if any, necessary for the provision of Services to the Receiving Party during the Term. The Service Provider agrees to use commercially reasonable efforts to assist the Receiving Party in its negotiations with any licensors from whom the Receiving Party may require such a license (or consent or extension) during the Term. In the event the Receiving Party is unable to obtain a necessary license, consent or extension, the Services related to such license shall be removed from the scope of the TSA, without a reduction in fees or payments owed by the Receiving Party under the TSA. In all events, and in addition to (and not in limitation of) any similar rights that the Service Provider may have under the TSA, the Receiving Party shall indemnify, defend and hold the Service Provider harmless from and against any actions, liabilities and/or claims relating to the licenses and the license matters discussed in this provision. The Receiving Party’s obligation to pay any fees under this Section 1.5 shall apply whether or not such claims for fees arise from the Receiving Party’s continued or past access to or benefit from third party intellectual property. The Receiving Party also acknowledges the Service Provider’s right to initiate discussion with third party licensors that may involve the Receiving Party’s use of intellectual property. All negotiated agreements with third party licensors for the future use of or rights to intellectual property and associated services shall be at the cost of the Service Provider, provided that the Receiving Party shall bear the cost of incremental third party use fees which are specifically identified in the agreements with the third party licensors and which relate solely to the Receiving Party’s use (“Incremental License Fees”). Such Incremental License Fees shall be approved in advance in writing by the Receiving Party, which approval shall not be unreasonably withheld or delayed.

  • Development License Subject to the terms and conditions of this XXXX, You are licensed to perform an installation of the SOFTWARE for an unlimited use in designing, testing and creating Developed Software by unlimited Developers on one or more computers.

Time is Money Join Law Insider Premium to draft better contracts faster.